Eurofins: EPS up 41% in 2024

(CercleFinance.com) - Eurofins Scientific reports EPS for 2024 up 41% to 1.
87 euros, and adjusted EBITDA up 13.8% to 1.55 billion euros, in line with the mid-point of its October target range.

Also in line with its latest forecast of 'close to seven billion euros', the bio-analysis services group's sales rose by 6.7% to 6.95 billion (+4.7% organic), surpassing its previous Covid-19 record.

"After the disruptions caused by the pandemic and the war in Ukraine, 2024 was the first year of relative stability since 2019, where the continuation of our historical trends of profitability growth and are clearly visible," it emphasizes.

For fiscal 2025, Eurofins anticipates, in particular, an adjusted EBITDA margin improving on last year's level of 22.3%, as well as organic growth in the mid-single-digit range.

Copyright (c) 2025 CercleFinance.com. All rights reserved.